TORRENTE, YVAN
 Distribuzione geografica
Continente #
EU - Europa 16.422
NA - Nord America 11.143
AS - Asia 5.965
SA - Sud America 225
OC - Oceania 46
AF - Africa 40
Continente sconosciuto - Info sul continente non disponibili 15
Totale 33.856
Nazione #
US - Stati Uniti d'America 10.739
GB - Regno Unito 5.601
DE - Germania 2.651
IT - Italia 2.645
CN - Cina 2.451
SE - Svezia 1.827
SG - Singapore 1.049
RU - Federazione Russa 749
IN - India 650
UA - Ucraina 610
TR - Turchia 587
IE - Irlanda 546
KR - Corea 511
FR - Francia 424
FI - Finlandia 393
CA - Canada 366
EU - Europa 332
NL - Olanda 314
HK - Hong Kong 214
PL - Polonia 175
CO - Colombia 156
ID - Indonesia 135
DK - Danimarca 115
JP - Giappone 102
VN - Vietnam 86
GR - Grecia 81
BE - Belgio 78
CH - Svizzera 56
BR - Brasile 46
IR - Iran 44
AU - Australia 40
RO - Romania 36
MX - Messico 33
ES - Italia 32
TW - Taiwan 27
CZ - Repubblica Ceca 26
UZ - Uzbekistan 25
IL - Israele 20
AT - Austria 15
CL - Cile 13
MY - Malesia 12
PT - Portogallo 12
TH - Thailandia 12
SC - Seychelles 11
EG - Egitto 10
PK - Pakistan 8
PH - Filippine 7
NO - Norvegia 6
NZ - Nuova Zelanda 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 4
HU - Ungheria 4
IQ - Iraq 4
ZA - Sudafrica 4
AL - Albania 3
AR - Argentina 3
BD - Bangladesh 3
HR - Croazia 3
MA - Marocco 3
PE - Perù 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
BG - Bulgaria 2
BT - Bhutan 2
CI - Costa d'Avorio 2
GL - Groenlandia 2
IS - Islanda 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LT - Lituania 2
LU - Lussemburgo 2
LY - Libia 2
NG - Nigeria 2
RS - Serbia 2
VE - Venezuela 2
AO - Angola 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
CY - Cipro 1
EC - Ecuador 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
KE - Kenya 1
LC - Santa Lucia 1
LI - Liechtenstein 1
MK - Macedonia 1
MU - Mauritius 1
SO - Somalia 1
TN - Tunisia 1
ZM - Zambia 1
Totale 34.173
Città #
Southend 5.228
Chandler 1.206
Seattle 965
Milan 821
Princeton 730
Wilmington 670
Singapore 637
Frankfurt am Main 635
Beijing 595
Dublin 539
Fairfield 530
Ashburn 493
Jacksonville 435
Mountain View 402
Redmond 369
Ann Arbor 353
Nanjing 322
Hanover 319
Woodbridge 297
Toronto 261
Munich 242
Houston 232
Bengaluru 230
Des Moines 225
Sakarya 217
Boardman 213
Dearborn 206
Hong Kong 184
Cambridge 181
Phoenix 176
Medford 167
Serra 159
Warsaw 150
Andover 141
Bogotá 141
Shenyang 116
Nanchang 105
Helsinki 104
Somerville 104
Jinan 103
Eitensheim 96
Redwood City 93
Shanghai 92
Sunnyvale 89
Berlin 85
Changsha 84
New York 82
Rome 81
Hebei 76
Athens 75
San Diego 73
Jakarta 70
Santa Clara 65
Tianjin 61
Brussels 60
Guangzhou 59
Turin 58
Hamburg 53
London 53
Bitonto 52
Istanbul 51
Hangzhou 50
Portici 50
Odernheim 48
Zhengzhou 46
Los Angeles 45
Roxbury 40
Kiez 39
Columbus 38
Ottawa 38
Jiaxing 35
Chicago 34
Falls Church 31
Auburn Hills 29
Ningbo 29
Norwalk 28
Nürnberg 28
Seoul 28
Fuzhou 27
Kunming 27
Mumbai 27
Grafing 26
Nuremberg 26
Leiden 24
Tokyo 24
Daejeon 23
Haikou 23
Lanzhou 23
Washington 22
Atlanta 21
Bühl 21
Hefei 21
São Paulo 21
Taizhou 21
Boston 20
Naples 20
Silver Spring 20
Kent 19
Pisa 19
Zurich 19
Totale 21.841
Nome #
Effect of human skin-derived stem cells on vessel architecture, tumor growth, and tumor invasion in brain tumor animal models 333
Effect of myofibril architecture on the active contraction of dystrophic muscle. A mathematical model 294
24 month longitudinal data in ambulant boys with Duchenne muscular dystrophy 267
CD133+ cells isolated from various sources and their role in future clinical perspective 266
Outcome measures validation study for mesoangioblasts transplantation in children affected by Duchenne Muscular Dystrophy 262
Purkinje cell COX deficiency and mtDNA depletion in an animal model of spinocerebellar ataxia type 1 243
Modificazione genica di cellule staminali distrofiche allo scopo di trapianto autologo nella distrofia muscolare di Duchenne 230
Allo-trapianto di mesoangioblasti da donatore hla-identico per la terapia cellulare della distrofia muscolare di Duchenne 228
Inositol 1,4,5-trisphosphate (IP3)-dependent Ca2+ signaling mediates delayed myogenesis in Duchenne muscular dystrophy fetal muscle 224
Long term natural history data in ambulant boys with duchenne muscular dystrophy: 36-month changes 198
Effects of rituximab in two patients with dysferlin-deficient muscular dystrophy 196
Stem cell–mediated transfer of a human artificial chromosome ameliorates muscular dystrophy 193
Blockade of IGF2R improves muscle regeneration and ameliorates Duchenne muscular dystrophy 193
6 minute walk test in duchenne MD patients with different mutations : 12 month changes 191
Impaired Angiogenic Potential of Human Placental Mesenchymal Stromal Cells in Intrauterine Growth Restriction 191
Supplementation with a selective amino acid formula ameliorates muscular dystrophy in mdx mice. 183
Autologous transplantation of muscle-derived CD133+ stem cells in Duchenne muscle patients 181
Immortalizzazione reversibile e trasduzione di mesoangioblastidmd con un cromosoma artificiale esprimente la distrofina per la terapia cellulare della distrofia muscolare 180
High Mobility group protein 3 (Hmgb3) is regulated by microRNA-206 during muscle regeneration 178
Combined effects of nutrients and gut microbiota in the immunomodulation of DMD 178
Preliminary evidences of safety and efficacy of flavonoids- and omega 3-based compound for muscular dystrophies treatment: a randomized double-blind placebo controlled pilot clinical trial. 177
T and b lymphocyte depletion has a marked effect on the fibrosis of dystrophic skeletal muscles in the scid/mdx mouse 176
A Special Amino-Acid Formula Tailored to Boosting Cell Respiration Prevents Mitochondrial Dysfunction and Oxidative Stress Caused by Doxorubicin in Mouse Cardiomyocytes 174
Stop codons, duplicazioni e delezioni: caratterizzazione genetica e follow-up clinico in una coorte di 201 pazienti affetti da distrofia Muscolare di Duchenne 172
Fate of autologous dermal stem cells transplanted into the spinal cord after traumatic injury (TSCI) 170
P(NIPAAM-co-HEMA) thermoresponsive hydrogels : an alternative approach for muscle cell sheet engineering 169
Induction of neurotrophin expression via human adult mesenchymal stem cells : implication for cell therapy in neurodegenerative diseases 164
Advancements in stem cells treatment of skeletal muscle wasting 164
Autologous intramuscular transplantation of engineered satellite cells induces exosomemediated systemic expression of Fukutin-Related Protein and rescues disease phenotype in a murine model of Limb-Girdle Muscular Dystrophy Type 2I. 163
Miopatia progressiva con ptosi, oftalmoplagia e aspetti distrofici alla biopsia muscolare 162
Heterogeneous tumorigenic capacity of human brain tumor derived neurospheres 162
Ruolo delle iPS nella medicina personalizzata 161
Morphological modifications of resected sciatic nerve after autologous transplantation of skin-derived stem cells into resorable guides. 160
Stem cells and muscular dystrophies 160
Expression of CD20 reveals a new store-operated calcium entry modulator in skeletal muscle 158
Intra-arterial transplantation of HLA-matched donor mesoangioblasts in Duchenne muscular dystrophy 158
Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells 157
Ruolo delle cellule staminali di derivazione cutanea nella rigenerazione assonale delle lesioni della 'dorsal root entry zone' midollare 156
Autologous transplantation of AC133+ stem cells in Duchenne muscular Dystrophy : preclinical and clinical evidences 155
Skin-derived stem cells transplanted into resorable guides provide functional nerve regeneration after sciatic nerve resection 155
Autologous transplantation of skin-derived stem cells and functional nerve regeneration after a peripheral nerve lesion 154
Functional and structural modifications of dystrophic muscles after autologous transplantation of muscle-derived AC133+ stem cells 154
Correlation of circulanting CD133+ progenitor subclasses with a Mild phenotype in Duchenne Muscular dystrophy patients 154
Combining Stem Cell and Exon Skipping Approach to Treat Muscular Dystrophies 153
Abundance of circulating progenitors with myo-endothelial potential correlates with a mild phenotype in patients affected by Duchenne muscular dystrophy 151
Heterogeneous tumourogenic ability of human brain tumour derived neurospheres 150
5'azacytidine enhances exogenous gene expression in muscle 150
Il trapianto di cellule staminali autologhe derivate da cute in guide tubolari riassorbibili favorisce la rigenerazione assonale nelle lesioni del nervo periferico 149
Le cellule staminali come approccio terapeutico della paralisi cerebrale infantile 149
Quantitative muscle strength assessment in Duchenne muscular dystrophy: longitudinal study and correlation with functional measures 149
Inclusion body myopathy and frontotemporal dementia caused by a novel VCP mutation 147
Stem cells in muscle diseases 147
Fibrin gels engineered with pro-angiogenic growth factors promote engraftment of pancreatic islets in extrahepatic sites in mice 146
Characterization of muscle-specific expression of miRNAs in duchenne muscular dystrophy 145
Abundance of circulating progenitors with myo-endothelial potential correlates with a mild phenotype in patients affected by Duchenne muscular dystrophy 144
Heterogeneous tumorigenic capacity of human brain tumor derived neurospheres 144
CD20-related signaling pathway is differently activated in normal and dystrophic circulating CD133+ stem cells 143
Bank of DNA, cell lines and nerve-muscle-cardiac tissues 143
Genotype and phenotype characterization in a large dystrophinopathic cohort with extended follow-up 143
Autologous transplantation of AC133+ stem cells in Duchenne muscular Dystrophy : preclinical and clinical evidences 142
VCAM-1 expression on dystrophic muscle vessels has a critical role in the recruitment of human blood-derived CD133+ stem cells after intra-arterial transplantation 140
Il trapianto di Mioblasti nelle Miopatie ereditarie 140
Human skin-derived stem cells inhibit brain tumor growth 139
Therapeutic Potential of Immunoproteasome Inhibition in DMD 139
Exome sequencing identifies variants in two genes encoding the LIM-proteins NRAP and FHL1 in an Italian patient with BAG3 myofibrillar myopathy 139
Combining stem cells and exon skipping strategy to treat muscular dystrophy 138
Timed Rise from Floor as a Predictor of Disease Progression in Duchenne Muscular Dystrophy : an Observational Study 138
Difference in myogenic properties of the blood-derived AC133+ stem cells subpopulation isolated from normal and dystrophic tissues 137
Cellule staminali e rigenerazione muscolare 137
Polyglycolic acid–polylactic acid scaffold response to different progenitor cell in vitro cultures : a demonstrative and comparative x-ray synchrotron radiation phase-contrast microtomography study 137
Autologous transplantation of bone marrow-derived CD133+ stem cells in facioscapulohumeral dystrophy 137
Therapeutic Potential of Immunoproteasome Inhibition in Duchenne Muscular Dystrophy 137
Generation of the Becker muscular dystrophy patient derived induced pluripotent stem cell line carrying the DMD splicing mutation c.1705-8 T>C 136
Human fetal CD133+ skeletal muscle cells expressing pericyte merkers generate muscle and endothelial cells and repair dystrophic muscle tissues. 135
MicroRNA-206 is upregulated in an animal model of Duchenne Muscular Distrophy 135
Some applications of nanotechnologies in stem cells research 134
Blood-derived CD133+ stem cells from normal and dystrophic tissues: a comparative study with clinical applications 133
5 ' azacytidine enhances exogenous gene expression in skeletal muscle 132
The myomiR-206 partecipate to muscle-regeneration by sculpting the chromatin through the down.regulation of the non-histone chromatin-associated protein High Mobility group protein 3 (Hmgb3) 132
Giant lysosomes as a chemotherapy resistance mechanism in hepatocellular carcinoma cells 132
Encefalomiopatie mitocondriali. Simposi in Medicina Clinica. Rivista Medica degli Ospedali di Milano IRCCS Ospedale Maggiore di Milano, Niguarda Cà Granda, San Carlo Borromeo e di Sesto S. Giovanni. The role of Molecular genetics in neurological diagnosis. Masson 89, (2): 177-186, 1995 131
Myogenic potential of human circulating AC133+ stem cells in murine dystrophic skeletal muscle 130
Rest is required for the regenerative response of skeletal muscle 130
Interstitial Cell Remodeling Promotes Aberrant Adipogenesis in Dystrophic Muscles. 130
Role of skin derived stem cells in peripheral nerve regeneration 127
Skin-derived stem cells transplanted into resorbable guides provide functional nerve regeneration after sciatic nerve resection 126
Development of a new technique for muscle tissues-stem cells co-colture 126
In vitro and In Vivo mesenchymal stem cells neurothrophin production but limited neuronal differantiation 125
MicroRNA-206 is upregulated in an animal model of Duchenne Muscular Distrophy. 125
Correction : Long term natural history data in ambulant boys with Duchenne muscular dystrophy : 36-month changes 125
Autologous skin derived stem cells and platelet-rich plasma as treatment for Traumatic spinal cord injury 124
Differential Activativation of CD20-Related Signalling Pathway Results in Distinct Differentiation Behaviour of Normal and DMD Circulating CD133+ Stem Cells 124
CD133+ Cells for the Treatment of Degenerative Diseases : update and perspectives 124
Effects of Composition of Alginate-Polyethylene Glycol Microcapsules and Transplant Site on Encapsulated Islet Graft Outcomes in Mice 124
Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor/stem-like cells isolated from nonfunctioning pituitary tumors 124
Cell Based Therapy for Duchenne Muscular Dystrophy 123
Development of new technologies Including myogenic differentiation of human circulating CD133+cells 123
Absence of T and B lymphocytes modulates dystrophic features in dysferlin deficient animal model 123
Activation of long non-coding RNA NEAT1 leads to survival advantage of multiple myeloma cells by supporting a positive regulatory loop with DNA repair proteins 122
Expression of parathyroid-specific genes in vascular endothelial progenitors of normal and tumoral parathyroid glands 122
Totale 15.874
Categoria #
all - tutte 101.416
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.416


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.995 0 0 156 253 228 346 358 212 568 496 247 131
2020/20213.856 135 308 256 87 396 232 315 236 434 241 979 237
2021/20224.168 264 216 133 250 279 308 314 218 583 323 400 880
2022/20235.305 757 521 450 509 597 939 175 363 593 105 198 98
2023/20243.390 124 235 176 198 858 213 198 190 114 239 345 500
2024/20251.301 343 801 157 0 0 0 0 0 0 0 0 0
Totale 36.365